Plasticell, Sphere Fluidics Partner for Gene Therapy ManufacturingBy
Plasticell, a biotechnology company using combinatorial cell-culture technologies for optimization of cell and gene therapy manufacturing, has formed a collaboration agreement with Sphere Fluidics, a company specializing in single-cell encapsulation and screening.
Plasticell has used its proprietary Combinatorial Cell Culture (CombiCult) platform to develop gene transduction protocols as alternatives to commercial transfection reagents currently used in gene-therapy trials. Sphere Fluidics has developed high-throughput single-cell manipulation and screening technology in picoliter volumes. The two partners aim to combine their technologies to develop quantitatively accurate gene transduction systems with improved efficiency, safety, and cost savings.